Neuromodulation Techniques in Chronic Refractory Coccydynia: A Narrative Review.

IF 4.1 2区医学 Q1 CLINICAL NEUROLOGY

Pain and Therapy Pub Date : 2024-02-01 Epub Date: 2024-01-04 DOI:10.1007/s40122-023-00572-4

Sarvenaz Rahimibarghani, Richard Morgan, Jose Juan Diaz

引用次数: 0

Abstract

Refractory coccydynia is a condition characterized by severe coccygeal pain and poses a challenging management dilemma for clinicians. Advancements in neuromodulation (NM) technology have provided benefits to people experiencing chronic pain that is resistant to standard treatments. This review aims to summarize the spectrum of current NM techniques employed in the treatment of refractory coccydynia along with their effectiveness. A review of studies in the scientific literature from 2012 to 2023 was conducted, revealing a limited number of case reports. Although the available evidence at this time suggests significant pain relief with the utilization of NM techniques, the limited scope and nature of the studies reviewed emphasize the need for large-scale, rigorous, high-level research in this domain in order to establish a comprehensive understanding of the role of NM and its effectiveness in the management of intractable coccydynia.

Abstract Image

查看原文本刊更多论文

慢性难治性尾骨痛的神经调控技术：叙述性综述。

难治性尾骨痛是一种以严重尾骨疼痛为特征的疾病，给临床医生带来了极具挑战性的治疗难题。神经调控（NM）技术的进步为对标准疗法有抵抗力的慢性疼痛患者带来了福音。本综述旨在总结目前用于治疗难治性尾骨痛的各种神经调控技术及其疗效。我们对 2012 年至 2023 年的科学文献中的研究进行了回顾，发现了数量有限的病例报告。尽管目前现有的证据表明，使用 NM 技术可显著缓解疼痛，但所回顾的研究范围和性质有限，这强调了在这一领域进行大规模、严格和高水平研究的必要性，以便全面了解 NM 在治疗难治性尾骨痛中的作用和有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pain and Therapy CLINICAL NEUROLOGY-

CiteScore

6.60

自引率

5.00%

发文量

110

审稿时长

6 weeks

期刊介绍： Pain and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of pain therapies and pain-related devices. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged. Areas of focus include, but are not limited to, acute pain, cancer pain, chronic pain, headache and migraine, neuropathic pain, opioids, palliative care and pain ethics, peri- and post-operative pain as well as rheumatic pain and fibromyalgia. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, trial protocols, short communications such as commentaries and editorials, and letters. The journal is read by a global audience and receives submissions from around the world. Pain and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.